Whos at Highest Risk for GLP-1-Related Bone Loss
CrossRef Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review Joanna Betlejewska, Joanna Hubska, Zuzanna Roszkowska, Aleksandra Maciejczyk, Dominika Bachurska, Jan Domaski, Maciej Miarka, Joanna Raszeja-Wyszomirska, Magorzata Bobrowicz, Urszula Ambroziak Biomedicines.2025
Yes, combining both therapies is possible and may offer complementary benefits, though cost and tolerability must be considered
If you forget to inject a dose of Byetta 60 minutes before a main meal, dont have the dose after you eat
GLP-1 is a natural hormone released from the gut that ultimately sends a signal to the liver, telling it to stop dumping sugar into the bloodstream (in this way it shares a similar therapeutic action to Metformin)